LEP and Alzheimer disease: Consequently, as there is good evidence that leptin-based therapies have therapeutic efficacy in individuals with low leptin levels, it feasible that the use of leptin-based therapies will have beneficial effects in AD, but the usefulness may be limited to a specific cohort of AD patients.